Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 7Phase NA 6Phase 1 3Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 416Radiotherapy 274fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 181Paclitaxel 176Carboplatin 167Magnetic Resonance Spectroscopy 164fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Capecitabine 124Temozolomide 123Specimen Handling 123Radiosurgery 117Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Oxaliplatin 110Fluorouracil 110Radiation 109Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Vitamin E × Clear all
NCT00096356 2021-09-29

CoQ10

Wake Forest University Health Sciences

Phase 1 Completed
236 enrolled 11 charts
Breast

Breast Neoplasms, Fatigue

NCT00905918 2014-09-30

Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer

Rutgers, The State University of New Jersey

Phase 1 Completed
14 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00895115 2012-06-14

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

Rutgers, The State University of New Jersey

Phase 1 Completed
65 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡